Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

ALPS Medical Breakthroughs ETF SBIO

Full chart Compare
Set alert

Price alert · SBIO

All alert types
54.13 USD +1.30 (+2.46%)

Nov 6, 2026, 10:48 AM EST

53.34 Day range 54.13
43.10 52-week range 70.85
YTD
+5.68%
1 year
+22.27%

ALPS Medical Breakthroughs ETF

Issuer
ALPS Funds
Asset class
Equity
Expense ratio
0.50%
Assets under management
$176.91M
NAV
52.81
Holdings
103
Inception
2014-12-30
Top 10 weight
31.45%

Top holdings

  1. ORKA Oruka Therapeutics Inc. 4.39%
  2. CGON CG oncology Inc. 3.92%
  3. MANE VeraDermics Inc. 3.73%
  4. TVTX Travere Therapeutics Inc. 3.23%
  5. DNTH Dianthus Therapeutics Inc. 3.14%
  6. DFTX Definium Therapeutics Inc. 2.87%
  7. EWTX Edgewise Therapeutics Inc. 2.66%
  8. RLAY Relay Therapeutics Inc. 2.59%
  9. XENE Xenon Pharmaceuticals Inc. 2.49%
  10. ACAD ACADIA Pharmaceuticals Inc. 2.42%
  11. AMLX Amylyx Pharmaceuticals Inc. 2.42%
  12. DYN Dyne Therapeutics Inc. 2.27%
  13. DNLI Denali Therapeutics Inc. 2.19%
  14. VRDN Viridian Therapeutics Inc. 2.16%
  15. IRON Disc Medicine Inc. 2.09%
  16. IDYA Ideaya Biosciences Inc. 2.04%
  17. TARS Tarsus Pharmaceuticals Inc. 1.98%
  18. XNCR Xencor Inc. 1.71%
  19. ZLAB Zai Lab Ltd. 1.68%
  20. MBX MBX Biosciences Inc. 1.65%
  21. NAMS Newamsterdam Pharma Co. NV 1.64%
  22. CLDX Celldex Therapeutics Inc. 1.54%
  23. PVLA Palvella Therapeutics Inc. 1.53%
  24. VCEL Vericel Corp. 1.53%
  25. VERA Vera Therapeutics Inc. 1.51%

Sector weights

  • Healthcare 100.00%

Country weights

  • United States 91.87%
  • Canada 2.37%
  • United Kingdom 1.83%
  • China 1.73%
  • Netherlands 1.62%
  • Switzerland 0.33%
  • Belgium 0.25%

Updated 2026-11-06